Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Alger Weatherbie Specialized Growth Fund H. George Dai, Joshua D. Bennett | “Neogen develops, manufactures, and markets a diverse range of products dedicated to food and animal safety. Its Food Safety segment includes diagnostic test kits and related products used by food producers and processors to detect harmful or unintended substances in human food and animal feed. Its Animal Safety segment provides pharmaceuticals, vaccines, veterinary instruments, and genomic testing services. Shares detracted from performance during the quarter after the company reported fiscal third-quarter revenue and profitability below expectations. Additionally, management modestly lowered its full-year 2025 guidance, citing a weaker macroeconomic environment impacting food production volumes and the strategic decision to exit non-core areas within its animal genomics business. BSD Analysis: Neogen is riding a global wave of food safety tightening, pathogen testing expansion, and livestock biosecurity mandates. The acquisition of 3M's food safety business solidified its dominance and unlocked synergies that are only now flowing through margins. Recurring consumables revenue keeps stacking, and Neogen's global distribution footprint gives it a moat most diagnostic players envy. Investors treat this like a sleepy ag-testing name — but the regulatory tailwinds in food and animal safety are enormous.” | BULL | Q2 2025 Jul 7, 2025 | View Pitch |
Conestoga Mid Cap Composite Conestoga Capital Advisors, LLC | “The manager decided to exit the position in Neogen due to persistent integration issues with 3M's food safety business and frequent changes in leadership. These struggles have degraded the company's fundamentals below the manager's long-term growth expectations.” | BEAR | Q2 2025 Jun 30, 2025 | View Pitch |
Alger Small Cap Focus Fund Amy Zhang | “Neogen develops, manufactures, and markets a diverse range of products dedicated to food and animal safety. Its Food Safety segment includes diagnostic test kits and related products used by food producers and processors to detect harmful or unintended substances in human food and animal feed. Its Animal Safety segment provides pharmaceuticals, vaccines, veterinary instruments, disinfectants, diagnostic products, rodenticides, and genomic testing services. Shares detracted from performance during the quarter after the company reported fiscal third-quarter revenue and profitability below expectations. Additionally, management modestly lowered its full-year 2025 guidance, citing a weaker macroeconomic environment impacting food production volumes and the strategic decision to exit non-core areas within its animal genomics business. BSD Analysis: Neogen is a food and animal safety platform riding secular growth in global biosecurity — a trend that's not slowing. The integration of the 3M food safety business gives it scale, cross-sell power, and a broader product suite. Margins are improving, operating leverage is building, and Neogen's recurring consumables revenue is sticky. Global regulations around testing, traceability, and contamination play directly into Neogen's hands. The company is still digesting acquisitions, but the long-term picture is a cleaner, stronger, more defensible business. The stock trades like a slow grower, but the fundamentals say otherwise.” | BULL | Q2 2025 Jun 30, 2025 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
